OCTOBER 7, 2019

FDA Approves ‘Low-Dose,’ Recharge-Free Neurostimulation System

The FDA approved the recharge-free neurostimulation system (Proclaim XR, Abbott) for the treatment of chronic pain.

To read the full story, Log in or Sign up for a Free Account

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select